Ledger.Open graph →
SEC Form D · filed July 26, 2023

Eterna Therapeutics Inc

Offering
$8.7M
Sold
$8.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Brant Binder · Cambridge, MADirectorSandra Gurrola · Cambridge, MAExecMatthew Angel · Cambridge, MAExec · DirectorRichard W. Wagner · Cambridge, MADirectorWilliam Wexler · Cambridge, MADirectorGregory Fiore · Cambridge, MADirectorWilliam Wexler · Cambridge, MADirectorRichard W. Wagner · Cambridge, MADirectorGregory Fiore · Cambridge, MADirectorMatthew Angel · Cambridge, MAExec · DirectorSandra Gurrola · Cambridge, MAExecBrant Binder · Cambridge, MADirectorSteve Sansom · Memphis, TNExecNeda Rama ARGA Group Holdings LLC · Stamford, CTDirectorFf Fund 3 GP, LLC · Tampa, FLDirectorFF Capital Partners, LLC · Tampa, FLDirectorDaniel S. Loeb · Hobe Sound, FLExec · DirectorFrank Scavone · Hobe Sound, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗